| For: | Wabont G, Ferret L, Houdre N, Lepied A, Bene J, Cousein E. Escitalopram-induced hepatitis: A case report. World J Clin Cases 2022; 10(8): 2468-2473 [PMID: 35434055 DOI: 10.12998/wjcc.v10.i8.2468] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i8/2468.htm |
| Number | Citing Articles |
| 1 |
Karan Kverno. VigiBase Pharmacovigilance Studies on Antidepressant-Related Adverse Reactions: A Scoping Review. Journal of Psychosocial Nursing and Mental Health Services 2024; 62(3): 7 doi: 10.3928/02793695-20240207-01
|
| 2 |
Liu-Cheng Li, Wen Sun, Xiao-Qin Lv, Yao-Yao Xu, Ying Hu, Jia-Na Shi. Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature. Frontiers in Cardiovascular Medicine 2024; 10 doi: 10.3389/fcvm.2023.1133662
|
| 3 |
Yuting Wang, Hafsa Ashfaq, Mansour Abdulaziz Alsaleem, Mohammed Alissa, Abdullah Alghamdi, Alaa S. Alhegaili, Ahmed Al-Emam, Hesham M. Hassan. Melitidin alleviates escitalopram-induced sub-chronic cardiotoxicity via regulating mitochondrial fission-fusion machinery and redox signaling: A biochemical, echocardiographic, and histological study. Tissue and Cell 2026; 101: 103435 doi: 10.1016/j.tice.2026.103435
|
| 4 |
|
